Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J M Niloff

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
Gynecologic Oncology|November 1, 1989
Adenocarcinoma of the cervical stumpH M Goodman, J M Niloff, C A Buttlar, et al.
American Journal of Obstetrics and Gynecology|July 1, 1986
The CA 125 assay as a predictor of clinical recurrence in epithelial ovarian cancerJ M Niloff, R C Knapp, P T Lavin, et al.
Gynecologic Oncology|May 1, 1989
Adenocarcinoma of the uterine cervix: prognostic factors and patterns of recurrenceH M Goodman, C A Buttlar, J M Niloff, et al.
The New England Journal of Medicine|October 13, 1983
A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancerR C Bast, T L Klug, E St John, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
Gynecologic Oncology|November 1, 1989
Adenocarcinoma of the cervical stumpH M Goodman, J M Niloff, C A Buttlar, et al.
American Journal of Obstetrics and Gynecology|July 1, 1986
The CA 125 assay as a predictor of clinical recurrence in epithelial ovarian cancerJ M Niloff, R C Knapp, P T Lavin, et al.
Gynecologic Oncology|May 1, 1989
Adenocarcinoma of the uterine cervix: prognostic factors and patterns of recurrenceH M Goodman, C A Buttlar, J M Niloff, et al.
The New England Journal of Medicine|October 13, 1983
A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancerR C Bast, T L Klug, E St John, et al.
Pageof 3